Menu

Full Sarkar Investigation Report Won’t Enter Appeals Court Case

Court of Appeals denies a motion filed by ACLU lawyers to enter the full Wayne State University investigation of pathologist Fazlul Sarkar into the official case record.

Dec 1, 2016
Bob Grant

WIKIMEDIA, BRIAN TURNERIn the latest twist in the legal battle between former Wayne State University researcher Fazlul Sarkar and PubPeer, an online post-publication peer review forum, the Michigan Court of Appeals has denied a motion to enter into the record the full report from a Wayne State investigation of allegations of misconduct made against Sarkar.

ACLU lawyers representing PubPeer were previously successful in submitting part of the Wayne State investigation results, first published in The Scientist. But the appeal court’s decision will block the full investigation, which found Sarkar guilty of misconduct, from being entered into the case. “This is as it should be, that the appeal is decided on the issues that were properly before the trial court only,” Nick Roumel, the attorney representing Sarkar, said in an email to The Scientist.

The Court heard arguments from both sides of the case—which revolves around Sarkar’s attempt to unmask anonymous PubPeer commenters who criticized his work—in October, but has yet to issue its decision.

The Scientist reached out to Alex Abdo, the lead ACLU attorney representing PubPeer, and we’ll update this story with comments from him and further thoughts from Roumel as soon as possible.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.